• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TNXP

TNXP

Tonix Pharmaceuticals Holding Corp.

NASDAQHealthcareBiotechnologyUS

USD11.40

-0.32 (-2.73%)

Rating:B-

Company Profile

CEO

Seth Lederman

IPO Date

2012-05-10

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$11.69

Prev. Close

$11.72

Day Low

$11.31

Day High

$11.69

52W Low

$11.31

52W High

$69.97

Market Cap

$0.18B

Volume

0.36M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBearish

Articles

10

Avg Positive

22.1%

Avg Negative

47.8%

Avg Neutral

30.3%

News Feed

Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs

GlobeNewsWire·7/27/2021·↑ positive

Why Tonix Pharmaceuticals Stock Is Crashing Today

The Motley Fool·7/26/2021·↓ negative

TNXP Stock Falls Over 30% Pre-Market: Why It Happened

Pulse2·7/26/2021·↓ negative

IDMC Recommends Tonix Pharma To Stop Enrollment In Fibromyalgia Trial; Shares Drop

Benzinga·7/26/2021·↓ negative

TNXP Stock Fell 2.97%: Why It Happened

Pulse2·7/23/2021·↓ negative

Tonix Pharmaceuticals Announces Outcome of Interim Analysis of Phase 3 RALLY Study of TNX-102 SL for the Management of Fibromyalgia

GlobeNewsWire·7/23/2021·↓ negative

Popular Penny Stocks to Buy Right Now? 7 For Your Watchlist

PennyStocks·7/2/2021·↑ positive

Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes

GlobeNewsWire·6/28/2021·↑ positive

TNXP Stock Price Increased 8.18%: Why It Happened

Pulse2·6/26/2021·↑ positive

Tonix Pharma Stock Moving Higher On Plans For Vaccine Manufacturing Facility In Bitterroot Valley

Benzinga·6/25/2021·↑ positive